Skip to main content

Table 1 Basic clinical characteristics between non-ACE and ACE group

From: Prognosis modelling of adverse events for post-PCI treated AMI patients based on inflammation and nutrition indexes

Item

non-ACE

ACE

P

N = 950

N = 128

Gender, n (%)

female

182 (16.88%)

35 (3.25%)

0.0402

male

768 (71.24%)

93 (8.62%)

AMI type, n (%)

NSTEMI

59 (5.47%)

5 (0.46%)

0.4029

STEMI

891 (82.65%)

123 (11.41%)

Killip Grade, n (%)

I

488 (45.27%)

25 (2.32%)

< 0.0001

II

287 (26.62%)

29 (2.69%)

III

74 (6.86%)

17 (1.58)

IV

101 (9.37%)

57 (5.29%)

Smoking, n (%)

590 (54.73%)

66 (6.12%)

0.0280

Hypertension, n (%)

467 (43.32%)

71 (6.59%)

0.2126

Diabetes, n (%)

170 (15.77%)

27 (2.50%)

0.4488

Hyperlipidemia, n (%)

683 (63.36%)

96 (8.91%)

0.5277

Hyperuricemia, n (%)

218 (20.22%)

50 (4.64%)

0.0001

Cerebrovascular accident, n (%)

58 (5.38%)

15 (1.39%)

0.0289